This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fukumoto, Y. Search for Related Content PubMed PubMed Citation Articles by Fukumoto, Y.

CLINICAL RESEARCH: INVASIVE AND INTERVENTIONAL CARDIOLOGY

The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study

^* Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

Manuscript received December 9, 2002; revised manuscript received January 6, 2003, accepted January 30, 2003.

^* Reprint requests and correspondence: Dr. Hiroyuki Tsutsui, Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
prehiro{at}cardiol.med.kyushu-u.ac.jp

OBJECTIVES: We sought to determine the incidence of cholesterol embolization syndrome (CES) as a complication of cardiac catheterization and to identify risk factors associated with this disease.

BACKGROUND: Cholesterol embolization syndrome is a systemic disease caused by distal showering of cholesterol crystals after angiography, major vessel surgery, or thrombolysis.

METHODS: We prospectively evaluated a total of 1,786 consecutive patients 40 years of age and older, who underwent left-heart catheterization at 11 participating hospitals. The diagnosis of CES was made when patients had peripheral cutaneous involvement (livedo reticularis, blue toe syndrome, and digital gangrene) or renal dysfunction.

RESULTS: Twenty-five patients (1.4%) were diagnosed as having CES. Twelve patients (48%) had cutaneous signs, and 16 patients (64%) had renal insufficiency. Eosinophil counts were significantly higher in CES patients than in non-CES patients before and after cardiac catheterization. The in-hospital mortality rate was 16.0% (4 patients), which was significantly higher than that without CES (0.5%, p < 0.01). All four patients with CES who died after cardiac catheterization had progressive renal dysfunction. The incidence of CES increased in patients with atherosclerotic disease, hypertension, a history of smoking, and the elevation of baseline plasma C-reactive protein (CRP) by univariate analysis. The femoral approach did not increase the incidence, suggesting a possibility that the ascending aorta may be a potential embolic source. As an independent predictor of CES, multivariate regression analysis identified only the elevation of pre-procedural CRP levels (odds ratio 4.6, p = 0.01).

CONCLUSIONS: Cholesterol embolization syndrome is a relatively rare but serious complication after cardiac catheterization. Elevated plasma levels of pre-procedural CRP are associated with subsequent CES in patients who undergo vascular procedures.

Abbreviations and Acronyms   AMI = acute myocardial infarction   CES = cholesterol embolization syndrome   CRP = C-reactive protein

This article has been cited by other articles:

				M. S Parmar Progressive acute kidney injury following myocardial infarction: cholesterol embolisation BMJ Case Reports, February 22, 2009; 2009(feb22_1): bcr0620080103 - bcr0620080103. [Abstract] [Full Text]

				H. Tanizaki, K. Kabashima, K. Takahashi, T. Sakurai, Y. Tokura, and Y. Miyachi Artificial foreign body embolism after percutaneous cardiac catheterization. Arch Dermatol, August 1, 2006; 142(8): 1077 - 1078. [Full Text] [PDF]

				Y. P. Liew and J. R Bartholomew Atheromatous embolization Vascular Medicine, November 1, 2005; 10(4): 309 - 326. [Abstract] [PDF]

				H. D. Aronow, M. Shishehbor, D. A. Davis, I. L. Katzan, D. L. Bhatt, C. T. Bajzer, A. Abou-Chebl, K. W. Derk, P. L. Whitlow, and J. S. Yadav Leukocyte Count Predicts Microembolic Doppler Signals During Carotid Stenting: A Link Between Inflammation and Embolization Stroke, September 1, 2005; 36(9): 1910 - 1914. [Abstract] [Full Text] [PDF]

				M. Maeder, M. Klein, T. Fehr, and H. Rickli Contrast nephropathy: Review focusing on prevention J. Am. Coll. Cardiol., November 2, 2004; 44(9): 1763 - 1771. [Abstract] [Full Text] [PDF]

				Risk Factors for Cholesterol Embolization After Catheterization Journal Watch Cardiology, August 22, 2003; 2003(822): 5 - 5. [Full Text]